Section 1. Short title
This Act may be cited as the Allergen Disclosure In Non-food Articles Act or the ADINA Act.
(a) Misbranding
Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:
(hh) If it is a drug—
(1) that is intended for human use;
(2) that contains an ingredient that is, or is derived directly or indirectly from—
(A) a major food allergen; or
(B) a gluten-containing grain (including wheat, barley, rye, and their crossbred hybrids); and
(3) whose label fails—
(A) to state that the drug contains such an ingredient; and
(B) to identify each such ingredient and, as applicable, the type of gluten-containing grain.
(b) Applicability
Section 502(hh) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a), shall apply beginning on the earlier of—
(1) a date to be determined by the Secretary of Health and Human Services; or
(2) the date that is 2 years after the date of the enactment of this Act.